Compton, UK, 1 September, 2009 — Baxter International Inc. today announced that it has received approval to formally close its agreement with Edwards Lifesciences to acquire the Edwards’ haemofiltration business, also known as Continuous Renal Replacement Therapy (CRRT).

read more